Home » News
The INFRAPLUS’s kick-off took place over two productive days in Munich. With lively discussions and concrete plans, we have set the stage for INFRAFRONTIER’s expansion in state-of-the-art in vivo models, innovative in vitro models, preclinical services, and data analysis. All set to get started!
Biomedcode’s Tg197 human TNF transgenic mouse model of chronic destructive arthritis provides new insights on how combination treatment with Dasatinib and low-dose anti-TNF leads to synergistic senolytic effects on chondrocytes and effective treatment of arthritis.
A Biomedcode collaboration has developed a human-RANKL dependent breast cancer mouse model aiming to study disease mechanisms and establish preclinical platforms for the evaluation of human therapeutics targeting cancer.
A new publication of INFRAFRONTIER in Mammalian Genome is available on line now. Get an overview of the latest INFRAFRONTIER advancements, including services, resources, and technical developments.
In the INFRAFRONTIER2020 specialised phenotyping program, INFRAFRONTIER partner institutions offer the indepth characterisation of mouse mutants for interested biomedical researchers all around the globe. The call is free of charge for the user, concerning scientific service and expertise.
